Kenia Pissinate

Synthesis, cytotoxicity, and DNA-topoisomerase inhibitory activity of new asymmetric ureas and thioureas

Andressa Esteves-Souza, Kenia Pissinate, Maria da Graça Nascimento et al. · Bioorganic & Medicinal Chemistry · 2005 · 73 citations

Pharmacy, Biochemistry, Medicinal Chemistry +10

Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents

Ana Flávia Borsoi, Josiane Delgado Paz, Bruno Lopes Abbadi et al. · European Journal of Medicinal Chemistry · 2020 · 52 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

2-(Quinolin-4-yloxy)acetamides Are Active against Drug-Susceptible and Drug-Resistant <i>Mycobacterium tuberculosis</i> Strains

Kenia Pissinate, Anne Drumond Villela, Valnês S. Rodrigues-Junior et al. · ACS Medicinal Chemistry Letters · 2016 · 51 citations

Medicine, Medicinal Chemistry, Pharmacology +15

New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis

Bruno Couto Giacobbo, Kenia Pissinate, Valnês S. Rodrigues-Junior et al. · European Journal of Medicinal Chemistry · 2016 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity

Fernanda Souza Macchi, Kenia Pissinate, Anne Drumond Villela et al. · European Journal of Medicinal Chemistry · 2018 · 28 citations

Pharmacy, Chemistry, Medicinal Chemistry +12